APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease

Cited by (259)

Items 101–200 of 259

1. Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol
   Vladimir Rudajev, Jiřı́ Novotný · 2023 · Cell & Bioscience
2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer’s disease
   Collins, Jessica M., King, Anna E., Woodhouse, Adele, Kirkcaldie, Matthew T.K., Vickers, James C. · 2015 · Experimental Neurology
3. Chemical Cross-Linking/Mass Spectrometry Maps the Amyloid β Peptide Binding Region on Both Apolipoprotein E Domains
   Stéphanie Deroo, Florian Stengel, Azadeh Mohammadi, Nicolas Henry, Ellen Hubin, Eva‐Maria Krammer, Ruedi H. Aebersold, Vincent Raussens · 2014 · ACS Chemical Biology
4. Epidermal growth factor prevents APOE4 -induced cognitive and cerebrovascular deficits in female mice
   Riya Thomas, Alan W. J. Morris, Leon M. Tai · 2017 · Heliyon
5. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier
   Ben Shackleton, Charis Ringland, Laila I. Abdullah, MICHAEL J. MULLAN, Fiona Crawford, Corbin J. Bachmeier · 2019 · Molecular Neurobiology
6. Influence of Woodsmoke Exposure on Molecular Mechanisms Underlying Alzheimer’s Disease: Existing Literature and Gaps in Our Understanding
   Adam J. Schuller, Luke B. Montrose · 2020 · Epigenetics Insights
7. ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer’s disease mouse model
   Chan, Elizabeth S., Shetty, Mahesh Shivarama, Sajikumar, Sreedharan, Chen, Christopher, Soong, Tuck Wah, Wong, Boon-Seng · 2016 · Scientific Reports
8. ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease
   Krishnamurthy, Kamesh, Cantillana, Viviana, Wang, Haichen, Sullivan, Patrick M., Kolls, Bradley J., Ge, Xintong, Lin, Yufeng, Mace, Brian, Laskowitz, Daniel T. · 2020 · Brain Research
9. The Continuing Failure of Bexarotene in Alzheimer’s Disease Mice
   Claudia Balducci, Alessandra Paladini, Edoardo Micotti, Daniele Tolomeo, Pietro La Vitola, Emanuele Grigoli, Jill C. Richardson, Gianluigi Forloni · 2015 · Journal of Alzheimer s Disease
10. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
    Jesus J. Campagna, Patricia R. Spilman, Barbara M. Jagodzinska, Dongsheng Bai, Asa Hatami, Chunni Zhu, Tina V. Bilousova, Michael Jun, Chris Jean Elias, Johnny D. Pham et al. · 2018 · Scientific Reports
11. Mouse brain transcriptome responses to inhaled nanoparticulate matter differed by sex and APOE in Nrf2-Nfkb interactions
    Amin Haghani, Mafalda Cacciottolo, Kevin R. Doty, Carla D’Agostino, Max Andrew Thorwald, Nikoo Safi, Morgan E. Levine, Constantinos Sioutas, Terrence Town, Henry Jay Forman et al. · 2020 · eLife
12. Concerning the structure of apoE
    Carl Frieden, Kanchan Garai · 2013 · Protein Science
13. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease
    Fernandez-Martos, Carmen M., King, Anna E., Atkinson, Rachel A.K., Woodhouse, Adele, Vickers, James C. · 2015 · Neurobiology of Aging
14. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease
    Jia Luo, Sue Lee, Lawren A. VandeVrede, Zhihui Qin, Manel Ben Aissa, John Larson, Andrew F. Teich, Ottavio Arancio, Yohan D’Souza, Ahmed Elharram et al. · 2016 · Molecular Neurodegeneration
15. The Interplay Between Apolipoprotein E4 and the Autophagic–Endocytic–Lysosomal Axis
    Schmukler, E., Michaelson, D. M., Pinkas-Kramarski, R. · 2018 · Molecular Neurobiology
16. Relevance of transgenic mouse models for Alzheimer's disease
    Leon M. Tai, Juan Maldonado Weng, Mary Jo LaDu, Scott T. Brady · 2020 · Progress in molecular biology and translational science
17. LPC-DHA/EPA-Enriched Diets Increase Brain DHA and Modulate Behavior in Mice That Express Human APOE4
    Sarah B. Scheinman, Sugasini Dhavamani, Monay Zayed, Poorna C. R. Yalagala, Felecia M. Marottoli, Papasani Venkata Subbaiah, Leon M. Tai · 2021 · Frontiers in Neuroscience
18. A non-invasive, rapid method to genotype late-onset Alzheimer′s disease-related apolipoprotein E gene polymorphisms
    Li Yi, Ting Wu, Wenyuan Luo, Wenxia Zhou, Jun Wu · 2014 · Neural Regeneration Research
19. Spatial memory deficits in a mouse model of late-onset Alzheimer’s disease are caused by zinc supplementation and correlate with amyloid-beta levels
    Jane M. Flinn, P. Lorenzo Bozzelli, Paul Anthony Adlard, Angela M. Railey · 2014 · Frontiers in Aging Neuroscience
20. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
    Amanda B. Chai, Hin Hei Julian Lam, Maaike Kockx, Ingrid C. Gelissen · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
21. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice
    Francesca Lattanzio, Lucia Carboni, Donatella Carretta, Roberto Rimondini, Sanzio Candeletti, Patrizia Romualdi · 2013 · Neuroscience
22. Administering crocin ameliorates anxiety‐like behaviours and reduces the inflammatory response in amyloid‐beta induced neurotoxicity in rat
    Mohammadmehdi Hadipour, Zahra Bahari, Mohammad Reza Afarinesh, Zohreh Jangravi, Hossein Shirvani, Gholam Hossein Meftahi · 2021 · Clinical and Experimental Pharmacology and Physiology
23. Human ApoE ε4 Alters Circadian Rhythm Activity, IL-1β, and GFAP in CRND8 Mice
    John J. Graybeal, P. Lorenzo Bozzelli, Lacey L. Graybeal, Caitlin M. Groeber, Patrick E. McKnight, Daniel N. Cox, Jane M. Flinn · 2014 · Journal of Alzheimer s Disease
24. Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
    Takeda, Keisuke, Uda, Aoi, Mitsubori, Mikihiro, Nagashima, Shun, Iwasaki, Hiroko, Ito, Naoki, Shiiba, Isshin, Ishido, Satoshi, Matsuoka, Masaaki, Inatome, Ryoko et al. · 2021 · Communications Biology
25. Air pollution exposure during pregnancy and childhood, APOE ε4 status and Alzheimer polygenic risk score, and brain structural morphology in preadolescents
    Esmée Essers, Anne-Claire Binter, Alexander Neumann, Tonya J.H. White, Silvia Alemany, Mònica Guxens · 2022 · Environmental Research
26. APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia
    Preman, Pranav, Moechars, Daan, Fertan, Emre, Wolfs, Leen, Serneels, Lutgarde, Shah, Disha, Lamote, Jochen, Poovathingal, Suresh, Snellinx, An, Mancuso, Renzo et al. · 2024 · EMBO Molecular Medicine
27. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
    Deebika Balu, Ana Carolina Valencia‐Olvera, Austin Q. Nguyen, Mehul Patnam, Jason M. York, Francesco Peri, Frank Neumann, Mary Jo LaDu, Leon M. Tai · 2023 · Alzheimer s Research & Therapy
28. Microglial transcription profiles in mouse and human are driven by APOE4 and sex
    V. Alexandra Moser, Michael J. Workman, Samantha J. Hurwitz, Rachel M. Lipman, Christian J. Pike, Clive N. Svendsen · 2021 · iScience
29. Overexpression of serum amyloid a 1 induces depressive-like behavior in mice
    Woo Young Jang, Bo-Ram Lee, Jain Jeong, Younghun Sung, Minjee Choi, Song Park, Hyerim Kim, Soyoung Jang, Hyunmin Kim, Kyung-Il Joo et al. · 2016 · Brain Research
30. Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice
    Caleb E. Finch, Sara Shams · 2016 · Trends in Neurosciences
31. APOE genotype affects metabolic and Alzheimer‐related outcomes induced by Western diet in female EFAD mice
    Amy Christensen, Christian J. Pike · 2018 · The FASEB Journal
32. How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease
    Junjun Ni, Zhen Xie, Zhenzhen Quan, Jie Meng, Hong Qing · 2023 · Glia
33. Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer’s Disease and Type 2 Diabetes
    Manel Ben Aissa, Cutler T. Lewandowski, Kiira M Ratia, Sue Lee, Brian Thomas Layden, Mary Jo LaDu, Gregory R. J. Thatcher · 2021 · ACS Pharmacology & Translational Science
34. FT-ICR Mass Spectrometry Imaging at Extreme Mass Resolving Power Using a Dynamically Harmonized ICR Cell with 1ω or 2ω Detection
    Mathieu Tiquet, Raphaël La Rocca, Stefan Kirnbauer et al. · 2022 · Analytical Chemistry
35. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice
    Chan, Elizabeth S, Chen, Christopher, Cole, Gregory M, Wong, Boon-Seng · 2015 · Scientific Reports
36. Identification and modification of amyloid-independent phenotypes of APOE4 mice
    Amanda Marie DiBattista, Sonya B. Dumanis, Joshua Newman, George William Rebeck · 2016 · Experimental Neurology
37. The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models
    Gabriella MacDougall, Logan Y. Brown, Boris Kantor, Ornit Chiba‐Falek · 2021 · Molecular Therapy
38. Animal models of Alzheimer’s disease: preclinical insights and challenges
    Qingqing Xu, Wen Yang, Mei Zhong, Zhi‐Xiu Lin, Nora E. Gray, Yan‐Fang Xian · 2023 · Acta Materia Medica
39. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
    Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova, Thomas Wısnıewskı · 2018 · Journal of Alzheimer s Disease
40. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease
    Charis Ringland, Jonas Elias Schweig, Daniel Paris, Ben Shackleton, Cillian Lynch, Maxwell Eisenbaum, MICHAEL J. MULLAN, Fiona Crawford, Laila I. Abdullah, Corbin J. Bachmeier · 2020 · Neurobiology of Aging
41. Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
    Cillian Lynch, Maxwell Eisenbaum, Moustafa Algamal, Matilde Balbi, Scott Ferguson, Benoit Mouzon, Nicole A. Saltiel, Joseph O. Ojo, Ramon R. Diaz-Arrastia, Mike Mullan et al. · 2020 · Journal of Cerebral Blood Flow & Metabolism
42. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha
    Lisa R. Taxier, Sarah M. Philippi, Jason M. York, Mary Jo LaDu, Karyn M. Frick · 2021 · Neurobiology of Aging
43. High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
    Pedrini, Steve, Chatterjee, Pratishtha, Hone, Eugene, Martins, Ralph N. · 2021 · Journal of Neurochemistry
44. Independent <scp> <i>APOE4</i> </scp> knock‐in mouse models display reduced brain <scp>APOE</scp> protein, altered neuroinflammation, and simplification of dendritic spines
    Sepulveda, Jordy, Luo, Nancy, Nelson, Matthew, Ng, Christi Anne S., Rebeck, George William · 2022 · Journal of Neurochemistry
45. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes
    Jianjia Fan, Shahab Zareyan, Wenchen Zhao, Yoko Shimizu, Tom A. Pfeifer, Jun‐Hyung Tak, Murray B. Isman, Bernard G. Van den Hoven, Mark E. Duggan, Michael W. Wood et al. · 2016 · PLoS ONE
46. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain
    Bruce Teter, Mary Jo LaDu, Patrick M. Sullivan, Sally Ann Frautschy, Greg M. Cole · 2016 · Neuroreport
47. Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Oblak, Adrian L., Kotredes, Kevin P., Pandey, Ravi S., Reagan, Alaina M., Ingraham, Cynthia, Perkins, Bridget, Lloyd, Christopher, Baker, Deborah, Lin, Peter B., Soni, Disha M. et al. · 2022 · Frontiers in Aging Neuroscience
48. Animal Models of Alzheimer’s Disease
    Morgan Newman, Doris Kretzschmar, Imran Khan, Mengqi Chen, Giuseppe Verdile, Michael T. Lardelli · 2017 · Elsevier eBooks
49. Deciphering Brain Function by Miniaturized Fluorescence Microscopy in Freely Behaving Animals
    Sarah Malvaut, Vlad-Stefan Constantinescu, Harold Dehez, Sead Dorić, Armen Saghatelyan · 2020 · Frontiers in Neuroscience
50. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
    Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Cody Allen, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2022 · Alzheimer s Research & Therapy
51. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4
    Simone M. Crivelli, Qian Luo, Daan van Kruining, Caterina Giovagnoni, Marina Mané-Damas, Sandra den Hoedt, Dušan Berkeš, Helga E. de Vries, Monique T Mulder, Jochen Walter et al. · 2022 · Biomedicine & Pharmacotherapy
52. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease
    Lisa R. Taxier, Sarah M. Philippi, Aaron W. Fleischer, Jason M. York, Mary Jo LaDu, Karyn M. Frick · 2022 · Neurobiology of Aging
53. Impaired memory-guided attention in asymptomatic APOE4 carriers
    Jacqueline F. Zimmermann, Claude Alain, Christopher Butler · 2019 · Scientific Reports
54. Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe
    Simone M. Crivelli, Daan van Kruining, Qian Luo, Jo Stevens, Caterina Giovagnoni, Andreas Paulus, Matthias Bauwens, Dušan Berkeš, Helga E. de Vries, Monique T Mulder et al. · 2020 · Scientific Reports
55. APOE4 Promotes Tonic-Clonic Seizures, an Effect Modified by Familial Alzheimer’s Disease Mutations
    Lamoureux, Lorissa, Marottoli, Felecia M., Tseng, Kuei Y., Tai, Leon M. · 2021 · Frontiers in Cell and Developmental Biology
56. Immune dysfunction in Alzheimer disease
    Oleg Butovsky, Neta Rosenzweig, Kilian L. Kleemann, Mehdi Jorfi, Vijay Kumar Kuchroo, Rudolph E. Tanzi, Howard L. Weiner · 2025 · Nature reviews. Neuroscience
57. Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice
    Mafalda Cacciottolo, Todd E. Morgan, Caleb E. Finch · 2021 · Neurobiology of Aging
58. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
    Ana Carolina Valencia‐Olvera, Deebika Balu, Naomi Faulk, Aspasia Amiridis, Yueting Wang, Christine Pham, Eva Avila-Munoz, Jason M. York, Gregory R. J. Thatcher, Mary Jo LaDu · 2023 · Neurotherapeutics
59. Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume
    Steve Pedrini, James D. Doecke, Eugene Hone, Penghao Wang, Rohith N. Thota, Ashley Ian Bush, Christopher Cleon Rowe, Vincent Doré, Victor L. Villemagne, David J. Ames et al. · 2022 · Journal of Neurochemistry
60. Spontaneous and familial models of Alzheimer's disease: Challenges and advances in preclinical research
    Suryapriya Ulaganathan, Arunkumar Pitchaimani · 2023 · Life Sciences
61. Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before
    Liying Corinne Lee, Michele Q. L. Goh, Edward H. Koo · 2017 · BioEssays
62. Genetic Insights into Alzheimer's Disease
    Caitlin S. Latimer, Katherine L. Lucot, Christopher Dirk Keene, Brenna Cholerton, Thomas Jude Montine · 2021 · Annual Review of Pathology Mechanisms of Disease
63. Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice
    Sandra den Hoedt, Simone M. Crivelli, Frank P. J. Leijten, Mario H. Losen, Jo Stevens, Marina Mané-Damas, Helga E. de Vries, Jochen Walter, Mina Mirzaian, Eric J.G. Sijbrands et al. · 2021 · Frontiers in Aging Neuroscience
64. APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer’s disease mice
    Terri‐Leigh Stephen, Bayla M Breningstall, Sharanya Suresh, Cassandra Joan McGill, Christian J. Pike · 2022 · Journal of Neuroinflammation
65. APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
    Deebika Balu, Ana Carolina Valencia‐Olvera, Zarak Islam, Clare Mielczarek, Allison L. Hansen, Tamara M. Perez Ramos, Jason M. York, Mary Jo LaDu, Leon M. Tai · 2023 · Frontiers in Aging Neuroscience
66. Cerebrospinal Fluid Proteins as Regulators of Beta‐amyloid Aggregation and Toxicity
    Kayla M. Pate, Regina M. Murphy · 2017 · Israel Journal of Chemistry
67. Retinal dysfunction in APOE4 knock‐in mouse model of Alzheimer's disease
    Surabhi D. Abhyankar, Qianyi Luo, Gabriella D. Hartman, Neha S. Mahajan, Timothy W. Corson, Adrian L. Oblak, Bruce T. Lamb, Ashay Dilip Bhatwadekar · 2025 · Alzheimer s & Dementia
68. Validation and Characterization of a Novel Peptide That Binds Monomeric and Aggregated β-Amyloid and Inhibits the Formation of Neurotoxic Oligomers
    Renae K. Barr, Giuseppe Verdile, Linda Kurnia Wijaya, Michael Morici, Kevin Taddei, Veer Bala Gupta, Steve Pedrini, Liang Jin, Joseph A. Nicolazzo, Erin Knock et al. · 2015 · Journal of Biological Chemistry
69. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12
    Jordy Sepulveda, Jennifer Yejean Kim, Joseph Binder, Stefano Vicini, George William Rebeck · 2024 · Molecular Neurodegeneration
70. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease
    Xiaoli Wu, Jayasankar Kosaraju, Wei Zhou, Kin Yip Tam · 2018 · Neuropharmacology
71. Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE ε3, but not APOE ε4, targeted replacement mice
    Chunsun Jiang, Luke T. Stewart, Hui‐Chien Kuo, William McGilberry, Stephanie Brook Wall, Bill Liang, Thomas van Groen, Shannon M. Bailey, Young-il Kim, Trent E. Tipple et al. · 2019 · Neurobiology of Aging
72. Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory
    Biundo, Fabrizio, Ishiwari, Keita, Del Prete, Dolores, D’Adamio, Luciano · 2015 · Neurobiology of Learning and Memory
73. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
    Ana Carolina Valencia‐Olvera, Deebika Balu, Shreya Bellur, Thomas P. McNally, Yaseen Saleh, Don Pham, Shivesh Ghura, Jason M. York, Jan O. Johansson, Mary Jo LaDu et al. · 2023 · Alzheimer s Research & Therapy
74. Repetitive head trauma and apoE4 induce chronic cerebrovascular alterations that impair tau elimination from the brain
    Maxwell Eisenbaum, Andrew Pearson, Camila Ortiz, Milica Koprivica, Arianna Cembran, MICHAEL J. MULLAN, Fiona Crawford, Joseph O. Ojo, Corbin J. Bachmeier · 2024 · Experimental Neurology
75. Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
    Xinyue Li, Meina Quan, Yiping Wei, Wei Wang, Lingzhi Xu, Qi Wang, Jianping Jia · 2023 · Science China Life Sciences
76. APOE4 genotype or ovarian hormone loss influence open field exploration in an EFAD mouse model of Alzheimer's disease
    Lisa R. Taxier, Sarah M. Philippi, Jason M. York, Mary Jo LaDu, Karyn M. Frick · 2022 · Hormones and Behavior
77. Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction
    Steve Zaldua, Frederick C. Damen, Rohan Pisharody, Riya Thomas, Kelly D. Fan, Giri K. Ekkurthi, Sarah B. Scheinman, Sami Alahmadi, Felecia M. Marottoli, Simon T. Alford et al. · 2020 · Heliyon
78. Auditory or Audiovisual Stimulation Ameliorates Cognitive Impairment and Neuropathology in ApoE4 Knock-In Mice
    Harry Jung, Yeonkyeong Lee, Sang‐Hwa Lee, Jong‐Hee Sohn · 2023 · International Journal of Molecular Sciences
79. Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin.
    David Graykowski, Kyle Kasparian, John L. Caniglia, Yelena Gritsaeva, E. Cudaback · 2020 · Journal of Neuroimmunology
80. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
    Michael Klonarakis, Maya De Vos, Emma K. Woo, Liam T. Ralph, Jonathan S. Thacker, Joana Gil‐Mohapel · 2022 · Neuroscience & Biobehavioral Reviews
81. Cognitive deficits in human ApoE4 knock-in mice: A systematic review and meta-analysis
    Marieke J. G. van Heuvelen, Mathijs B. van der Lei, Pien M. Alferink, Peter Roemers, Eddy A. van der Zee · 2024 · Behavioural Brain Research
82. Sequential Proteomic Analysis Reveals the Key <scp>APOE4</scp>‐Induced Pathological and Molecular Features at the Presymptomatic Stage in Alzheimer's Disease Mice
    Wei, Pengju, Lin, Kaihua, Chen, Xuhui, Fang, Cheng, Qiu, Linhui, Hu, Jun, Chang, Junlei · 2025 · CNS Neuroscience &amp; Therapeutics
83. Effect of LXR/RXR agonism on brain and CSF Aβ40 levels in rats
    Songli Wang, Paul H. Wen, Stephen J. Wood · 2016 · F1000Research
84. mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer’s disease in an APOE genotype-dependent manner
    Basavaraju G. Sanganahalli, Jelena M. Mihailovic, Hemendra J. Vekaria, Daniel Coman, Andrew T. Yackzan, Abeoseh Flemister, Chetan B. Aware, Kathryn Wenger, W. Brad Hubbard, Patrick G. Sullivan et al. · 2024 · Journal of Cerebral Blood Flow & Metabolism
85. Pathological Human Astroglia in Alzheimer's Disease: Opening New Horizons with Stem Cell Technology
    Lisa Mohamet, Vicky C. Jones, Govindan Dayanithi, Alexei Verkhratsky · 2018 · Future Neurology
86. Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
    Leslie C. Norins · 2021 · Antibiotics
87. Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4
    Sarah B. Scheinman, Steve Zaldua, Adedoyin Dada, Kateryna Krochmaliuk, Katherine Dye, Felecia M. Marottoli, Gregory R. J. Thatcher, Leon M. Tai · 2021 · Frontiers in Neuroscience
88. The novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer’s mouse model
    Miranda R. Schwabe, Aaron W. Fleischer, Rachel K Kuehn, Shibani Chaudhury, Jason M. York, Daniel S. Sem, William A. Donaldson, Mary Jo LaDu, Karyn M. Frick · 2024 · Frontiers in Aging Neuroscience
89. The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
    Mohsen Karbasi Yazdi, Mohaddeseh Sadat Alavi, Ali Roohbakhsh · 2024 · Basic & Clinical Pharmacology & Toxicology
90. Enhanced Anti-Amyloid Effect of Combined Leptin and Pioglitazone in APP/PS1 Transgenic Mice
    Yao Liu, Kelsey Hanson, Graeme H. McCormack, Rachel A.K. Atkinson, Justin Dittmann, James Clement Vickers, Carmen María Fernández-Martos, Anna Elizabeth King · 2021 · Current Alzheimer Research
91. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer’s Disease
    Rebecca Atkinson-Dell, Lisa Mohamet · 2019 · Advances in experimental medicine and biology
92. APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice
    Ye Zhou, Wenjuan Zhao, Nour Al‐Muhtasib, George William Rebeck · 2015 · Journal of Alzheimer s Disease
93. Effects of APOE Genotype and Western Diet on Metabolic Phenotypes in Female Mice
    Amy Christensen, Christian J. Pike · 2023 · Metabolites
94. Effects of obesogenic diet and 17β-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes
    Amy Christensen, Cassandra Joan McGill, Wenjie Qian, Christian J. Pike · 2024 · Frontiers in Aging Neuroscience
95. Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOE
    Christi Anne S. Ng, Lucas P. Biran, Elena Galvano, Jeanne S. Mandelblatt, Stefano Vicini, George William Rebeck · 2022 · Neurobiology of Disease
96. Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer’s Disease
    Martine B. Grenon, Maria-Tzousi Papavergi, Praveen Bathini, Martin J. Sadowski, Cynthia Ann Lemere · 2024 · International Journal of Molecular Sciences
97. Not your mother's hormone therapy: Highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief
    Karyn M. Frick, Aaron W. Fleischer, Miranda R. Schwabe, Farah A. Abdelazim, Daniel S. Sem, William A. Donaldson · 2025 · Hormones and Behavior
98. Modeling Mixed Vascular and Alzheimer’s Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice
    Eric Y. Hayden, Julia Huang, Malena Charreton, Stefanie Nuñez, Jennifer N. Putman, Bruce Teter, Jason T. Lee, Andrew E. Welch, Sally Ann Frautschy, Gregory M. Cole et al. · 2020 · Translational Stroke Research
99. Inverse correlation between Alzheimer’s disease and cancer from the perspective of hypoxia
    Zhan Su, Guimei Zhang, Xiangting Li, Haining Zhang · 2023 · Neurobiology of Aging
100. A single fibril study reveals that ApoE inhibits the elongation of Aβ42 fibrils in an isoform-dependent manner
     Sourav Dasadhikari, Shamasree Ghosh, Sudip Pal, Tuomas P. J. Knowles, Kanchan Garai · 2025 · Communications Chemistry